MTOR and renal fibrosis: Preclinical models show that both KD and IF are effective in inhibiting the mTOR/AMPK pathway, cystogenesis, and renal fibrosis, and that these effects are specifically induced by ketosis, as demonstrated by the inhibition of PKD progression by the administration of b-hydroxybutyrate (120).